Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Indian J Cancer ; 2014 Jul-Sep; 51(3): 315-318
Artículo en Inglés | IMSEAR | ID: sea-154390

RESUMEN

Background: The observation of neuroendocrine activity during clinical course of ovarian cancer, suggested the use of neuroendocrine serum markers to detect this tumor. Aim: To evaluate the usefulness of serum measurements of chromogranin A (CgA) in the various stages of ovarian cancer. Materials and Methods: We measured serum concentrations of CgA and cancer antigen 125 (CA125) in 79 women at different clinical stages of ovarian cancer, enrolled between 2000 and 2007, and in a control group of 50 female volunteers. Results: CgA showed increased levels in patients with ovarian cancer as compared with healthy subjects, as it has been seen for CA125 serum levels. We also observed significant increase in CgA and CA125 serum levels when comparing patients with ovarian cancer in stage I versus stage II (P < 0.001); stage I versus stage III (P < 0.001); stage I versus stage IV (P < 0.001); stage II versus stage III (P < 0.001); stage II versus stage IV (P < 0.001). In patients with ovarian carcinoma in stage IV we observed a correlation between CgA and CA125 with a difference of 0.718 (P < 0.001). Conclusions: CgA serum levels were elevated in ovarian cancer and increased with the stage. Further studies are needed to elucidate the role of CgA as a prognostic indicator during treatment for ovarian cancer.


Asunto(s)
/sangre , Cromogranina A/sangre , Femenino , Humanos , Neoplasias Ováricas/inmunología , Pacientes , Biomarcadores de Tumor/sangre
2.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 5(6,supl.A): 24-6, nov.-dez. 1995. tab
Artículo en Portugués | LILACS | ID: lil-165732

RESUMEN

A assistência farmacêutica pode assumir, para o paciente transplantado, a mesma importância do medicamento, contribuindo de forma decisiva para o sucesso da terapêutica. Por meio de modernos sistemas de distribuiçäo e dispensaçäo de medicamentos, a atençäo farmacêutica pode garantir o medicamento, orientar o paciente quanto ao uso correto, aumentar sua aderência ao tratamento prescrito e prevenir efeitos colaterais ou interaçöes entre drogas. No InCor, o paciente internado recebe seus medicamentos Sistema de Dose Unitária, que assegura o medicamento certo para o paciente certo na hora certa. No que diz respeito ao ambulatório, a dispensaçäo se realiza pelo Sistema de Crédito Medicamentos, que permite acompanhamento frequente do paciente. Por meio da assistência farmacêutica, o farmacêutico torna-se co-responsável pela qualidade de vida do paciente submetido a transplante cardíaco.


Asunto(s)
Humanos , Trasplante de Corazón , Servicios Farmacéuticos , Preparaciones Farmacéuticas/provisión & distribución , Continuidad de la Atención al Paciente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA